Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
7.41
+1.33 (21.88%)
At close: Aug 7, 2026, 4:00 PM EDT
7.12
-0.29 (-3.91%)
Pre-market: Aug 10, 2026, 6:20 AM EDT

ARCT Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
29.3782.03152.31166.820612.36
Revenue Growth
-75.95%-46.14%-8.69%-19.03%1566.79%29.56%
Gross Profit
29.3782.03152.31166.820612.36
Operating Income
-102.3-76.26-95.67-78.2112.18-202.85
Net Income
-93.28-65.78-80.94-29.739.35-203.67
Earnings Per Share
-3.31-2.40-3.00-1.120.35-7.74
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
191.48230.91237.03292.01391.88370.49
Total Debt
18.9720.782525.9190.8767.61
Net Cash (Debt)
172.52210.13212.03266.1301.01302.88
Net Cash Growth
-0.59%-0.90%-20.32%-11.60%-0.62%-31.75%
Net Cash Per Share
6.157.677.859.9911.1111.51

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-72.73-74.27-59.75-18.131.99-135.04
Capital Expenditures
-0.09-0.23-0.65-2.9-7.73-3.41
Free Cash Flow
-72.82-74.5-60.4-2124.27-138.45
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-348.33%-92.96%-62.81%-46.89%5.91%-1641.33%
Pretax Margin
-317.64%-80.19%-53.14%-16.72%5.17%-1647.98%
Profit Margin
-317.62%-80.19%-53.14%-17.82%4.54%-1647.98%
FCF Margin
-247.97%-90.82%-39.65%-12.59%11.78%-1120.23%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----48.46-
Forward PE
-118.08118.08118.08118.084.34
P/FCF Ratio
----18.56-
PS Ratio
7.172.123.025.072.1978.97